fbpx

EMERGERS

Equity Research of
Nordic Growth Companies

Home

Författare: johan@emergers.se

NANEXA: Charging to enter triple clinical trials in the coming year

2022-10-26• Analys, Research

Besides starting its third proprietary development project in Q2 (NEX-22, a long-acting formulation of liraglutide for treatment of type 2...

Read More →

KEBNI: Saab order the portal to next level for KebNi

2022-10-17• Analys, Research

With the SEK 76m volume order for IMUs from Saab, KebNi now enters the next level of monetising its IMU technology. The order however only...

Read More →

GRANGEX: Upwards revision of reserves accompanied by strong macro backdrop

2022-09-21• Analys, Research

GRÄNGESBERG EXPLORATION The ongoing preparations for the DFS of Dannemora has now yielded its second upwards revision, a 16% increase in...

Read More →

NANEXA: New project NEX-22 to add significant daily benefits for 50m patient market

2022-09-16• Analys, Research

Nanexa’s next proprietary development project, NEX-22, is a long-acting formulation of liraglutide for treatment of type 2 diabetes...

Read More →

SIMRIS ALG: Cyano deal jumpstarts venture into Biopharma | See interview with CEO Julian Read

2022-09-07• Analys

With the successful completion of the acquisition of Berlin-based Cyano Biotech GmbH, Simris Alg is now set to accelerate their entry into...

Read More →

BONZUN: Set to refuel to latch on to global DTx trend

2022-09-02• Analys

The Q2’22 report showed some continued progress for Bonzun’s stress management service, Bonzun Evolve, with 450 new licenses from KTH...

Read More →

QLUCORE: CE headwind overshadows structural growth story

2022-09-01• Analys, Research

While the business side of Qlucore is moving steady forward, with 67% growth, two new Qlucore Insight license deals and an expansion of the...

Read More →

KEBNI: Strong momentum with near-term triggers to crystalise further upside potential

2022-08-30• Analys

Besides completing a capital raise in these challenging market conditions, KebNi enjoys strong business momentum with new antenna orders...

Read More →

DLABORATORY: Welcome boost from booming attention on power grid stability

2022-08-26• Analys

The rise of network stability and electricity security on the public agenda has finally started to translate into a material rise in...

Read More →

SIMRIS ALG: Accelerating entry into high-value BioPharma with acquisition of Cyano Biotech

2022-08-18• Analys

In line with their strategic plan to move into the highest margin application areas, Simris Alg announced an LOI to acquire Cyano Biotech...

Read More →

Actionable Investment Research | Sectors & Themes | Shorts and Frauds

Widmark Research 

CONTACT

Johan Widmark

Mail: johan@emergers.se
Tel: +46739196641

Östermalmsgatan 26A
114 26 Stockholm, Sweden

For new research on growth stocks, sign up to our newsletter